CDXS
Codexis, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.44
+1.06%0
Insider buys (3m)
1
Insider sells (3m)
-$6.2K
Net value (3m)
-43.6%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jun 18, 2026 | Collins Cynthia · director | A-Award | 66,350 | $2.48 |
| Jun 18, 2026 | Martinborough Esther · director | A-Award | 66,350 | $2.48 |
| Jun 18, 2026 | DILLY STEPHEN GEORGE · director | A-Award | 66,350 | $2.48 |
| Jun 18, 2026 | Singhvi Rahul · director | A-Award | 66,350 | $2.48 |
| Jun 18, 2026 | Smith David V · director | A-Award | 66,350 | $2.48 |
| Jun 18, 2026 | Richards Christos · director | A-Award | 66,350 | $2.48 |
| Jun 18, 2026 | De Vre Raymond · director | A-Award | 66,350 | $2.48 |
| Jun 18, 2026 | PARKER H STEWART · director | A-Award | 66,350 | $2.48 |
| Jun 11, 2026 | De Vre Raymond · director | Sale | 2,605 | $2.37 |
| Feb 25, 2026 | Lutz Stefan · officer: Chief Scientific Officer | A-Award | 316,100 | $1.07 |
| Feb 25, 2026 | Erbez Georgia · officer: See Remarks | A-Award | 316,100 | $1.07 |
| Feb 25, 2026 | MOORE ALISON · director, officer: President and CEO | A-Award | 993,000 | $1.07 |
| Feb 25, 2026 | Lutz Stefan · officer: Chief Scientific Officer | Sale | 5,862 | $1.13 |
| Feb 9, 2026 | MOORE ALISON · director, officer: President and CEO | Sale | 3,826 | $1.31 |
| Feb 9, 2026 | Lutz Stefan · officer: Chief Scientific Officer | Sale | 2,492 | $1.31 |
| Feb 9, 2026 | Erbez Georgia · officer: See Remarks | Sale | 3,826 | $1.31 |
| Jan 8, 2026 | Lutz Stefan · officer: CSO | Sale | 4,685 | $1.70 |
| Dec 15, 2025 | Opaleye Management Inc. · 10 percent owner | Sale | 296,682 | $1.70 |
| Dec 15, 2025 | Opaleye Management Inc. · 10 percent owner | Sale | 148,318 | $1.74 |
| Dec 1, 2025 | Opaleye Management Inc. · 10 percent owner | Sale | 148,318 | $1.74 |
| Dec 1, 2025 | Opaleye Management Inc. · 10 percent owner | Sale | 8,533 | $1.67 |
| Dec 1, 2025 | Opaleye Management Inc. · 10 percent owner | Sale | 2,490 | $1.75 |
| Dec 1, 2025 | Opaleye Management Inc. · 10 percent owner | Sale | 5,000 | $1.74 |
| Dec 1, 2025 | Opaleye Management Inc. · 10 percent owner | Sale | 245,000 | $1.67 |
| Dec 1, 2025 | Opaleye Management Inc. · 10 percent owner | Sale | 105,000 | $1.75 |
| Nov 25, 2025 | WOLF DENNIS P · director | Sale | 8,952 | $1.56 |
| Nov 17, 2025 | MOORE ALISON · officer: President and CEO | A-Award | 85,000 | $0.00 |
| Nov 17, 2025 | MOORE ALISON · officer: President and CEO | A-Award | 500,000 | $1.63 |
| Nov 14, 2025 | Opaleye Management Inc. · 10 percent owner | Sale | 890,000 | $1.94 |
| Nov 14, 2025 | Opaleye Management Inc. · 10 percent owner | Sale | 27,459 | $1.94 |
Institutional positioning
13F filings over the trailing two quarters
New 33Increased 46Reduced 39Sold out 133
| Filer | Action | Shares | Filed |
|---|---|---|---|
| ABRDN PLC | Increased | 8,680,368 | Apr 29, 2026 |
| BLACKROCK, INC. | Reduced | 7,028,773 | May 13, 2026 |
| OPALEYE MANAGEMENT INC. | Reduced | 6,785,000 | May 15, 2026 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | Increased | 4,123,613 | May 15, 2026 |
| MILLENNIUM MANAGEMENT LLC | Increased | 3,998,130 | May 15, 2026 |
| TELEMARK ASSET MANAGEMENT, LLC | Unchanged | 3,846,411 | May 12, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 3,668,507 | May 15, 2026 |
| AMERIPRISE FINANCIAL INC | Reduced | 3,400,496 | Jul 17, 2026 |
| UBS GROUP AG | Increased | 2,183,775 | May 5, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Reduced | 1,885,353 | May 15, 2026 |
| STATE STREET CORP | Increased | 1,666,954 | May 15, 2026 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | Reduced | 1,088,027 | May 15, 2026 |
| D. E. SHAW & CO., INC. | Increased | 979,847 | May 15, 2026 |
| JANE STREET GROUP, LLC | Increased | 919,964 | May 12, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 879,339 | May 8, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jun 18, 2026